John Morberg - Jan 18, 2024 Form 4 Insider Report for LIFECORE BIOMEDICAL, INC. \DE\ (LFCR)

Role
Chief Financial Officer
Signature
/s/ Aaron Perlitsh, Attorney-In-Fact for John Morberg
Stock symbol
LFCR
Transactions as of
Jan 18, 2024
Transactions value $
$0
Form type
4
Date filed
1/22/2024, 02:26 PM
Previous filing
Jun 5, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LFCR Common Stock Options Exercise +17.5K +15.3% 132K Jan 18, 2024 Direct F1
transaction LFCR Common Stock Tax liability -6.28K -4.76% 126K Jan 18, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LFCR Restricted Stock Unit Options Exercise $0 -17.5K -100% $0.00* 0 Jan 18, 2024 Common Stock 17.5K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis.
F2 The restricted stock units vested on January 18, 2024.